Piper Jaffray Starts Celyad SA (CYAD) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal optimism; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
UPDATE: UBS Starts Celyad SA (CYAD) at Buy
July 14, 2015 8:22 AM EDT(Updated - July 14, 2015 8:43 AM EDT)
UBS initiates coverage on Celyad SA (NASDAQ: CYAD) with a Buy rating and a price target of $82.00.
Analyst Andrew Peters commented, "We are initiating coverage on Celyad SA with a Buy rating and $82 price target following an extensive analysis of the phase-3 C-Cure program in heart failure as well as the NK-based CAR-T technology currently in phase-1 trials. We believe initial proofof-concept data from... More
